Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2019 October;71(5) > Minerva Pediatrica 2019 October;71(5):470-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Pediatrica 2019 October;71(5):470-4

DOI: 10.23736/S0026-4946.16.04445-5

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Central nervous system disease in childhood acute lymphoblastic leukemia

Mingwei JIN, Qi AN , Shumei XU

Department of Hematology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China



Acute lymphoblastic leukemia (ALL) is the commonest childhood malignancy. Despite therapeutic advancements, relapse of the pathological state in the form of central nervous system (CNS) disease remains a challenge. CNS disease appears to be present at diagnosis in at least 40% of patients. This relapse in the form of CNS disease is one of the major hurdles in achieving complete cure. The present review article aims to discuss the important mechanisms of leukemic entry and infiltration patterns of leukemic cells into the CNS. Also, latest updates in the management strategies of ALL will also be focused in the present article.


KEY WORDS: Precursor cell lymphoblastic leukemia-lymphoma; Central nervous system; Recurrence

top of page